Clinical Trials · NCT04938388
Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- Sansum Diabetes Research Institute
- Enrollment
- 12
- Start date
- Jan 2022
- Locations
- 1 site, United States
- Primary endpoint
- HbA1c < 7.0%